Major Drivers Propelling the Growth oh theArtificial Intelligence (AI) In Respiratory Diseases Market Forward: AI Revolutionizing Respiratory Health Addressing The Impact Of Growing Environmental Pollution
Discover trends, market shifts, and competitive outlooks for the artificial intelligence (ai) in respiratory diseases industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Is the Current and Projected Market Size of the Artificial Intelligence (AI) In Respiratory Diseases Market Through 2034?
The market size for artificial intelligence (AI) applications in respiratory diseases has seen substantial growth in the last few years. The market is projected to expand from $7.66 billion in 2024 to $8.05 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.1%. This growth in previous years can be traced back to factors such as stricter government rules, increasing awareness about the environment, a rise in the elderly population, emergence of patient-focused healthcare methods, and the expansion of healthcare infrastructure.
The market size of artificial intelligence (AI) in respiratory diseases is anticipated to experience robust growth in the coming years. It is projected to attain a value of $9.85 billion by 2029, with a compound annual growth rate (CAGR) of 5.2%. The predicted growth during the forecast period can be linked with the rising prevalence of respiratory diseases, the escalating needs for early detection and diagnosis, increasing environmental pollution, heightened spending on healthcare, and ongoing research and development initiatives. Key trends expected within the forecast period encompass technology advancements, drug discovery and development, personalized treatment plans, telemedicine and remote patient monitoring.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Artificial Intelligence (AI) In Respiratory Diseases Market?
The rise of environmental pollution is anticipated to spur the growth of artificial intelligence (AI) in the respiratory disease domain. The term environmental pollution pertains to any substance or form of energy added to the environment at a quicker pace than its harmless dispersion or storage. AI exhibits promise in substantially diminishing the repercussions of environmental pollution on respiratory wellness, through real-time surveillance, customized risk evaluations, informed decision making, and breakthrough solutions dedicated to individuals as well as communities. For instance, as reported by the US Energy Information Administration, a government agency based in the US, the CO2 emission in 2021 racked up to 35.72 billion metric tons, escalating to 38.50 billion metric tons in 2022 in June 2024. Consequently, the mounting environmental pollution is fuelling the growth of AI applications in the respiratory disease sector.
Which Key Market Segments Comprise the Artificial Intelligence (AI) In Respiratory Diseases Market and Drive Its Revenue Growth?
The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp
Which Areas Are Leading Regions in the Artificial Intelligence (AI) In Respiratory Diseases Market Expansion Across the Globe?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in the Artificial Intelligence (AI) In Respiratory Diseases Market Over the Coming Years?
Leading firms operating in the respiratory diseases market are focusing on Artificial Intelligence (AI) to devise innovative tools like N-Tidal devices that can track tidal breathing in patients. These devices measure the airflow during normal respiratory activity, which assists in evaluating lung performance. TidalSense, a British respiratory technology firm, introduced an N-Tidal regulated AI system for diagnosing and managing Chronic Obstructive Pulmonary Disease (COPD) in August 2023. This distinctive technology merges the CO2 sensor data from N-Tidal with an AI platform to identify alterations in lung performance. This aims to significantly enhance COPD’s diagnosis and management. Clinical research has confirmed the system’s superior accuracy, promising to revolutionize the diagnosis process for respiratory conditions. This development indicates a meaningful advancement in incorporating AI in assessing respiratory diseases, as it offers an easier and more efficient substitute for traditional diagnostic procedures.
View the full report here:
How Is the Artificial Intelligence (AI) In Respiratory Diseases Market Conceptually Defined?
Artificial intelligence (AI) in respiratory diseases refers to the use of AI and machine learning techniques to aid clinicians in the diagnosis, management, and treatment of various respiratory conditions. It has numerous potential applications in pulmonary medicine, including image analysis, predictive modeling, and disease management.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
